This stock takes a move upward after months of decline and they immediately announce the issuance of stock options to certain directors and consultants to purchase up to an aggregate of 600,000 common shares. The options have an exercise price of $0.20 per share and are exercisable for a period of five years from the date of granting. I'd be surprised if this stock doesn't return to its recent lows.